Skip to main content

Exuma Biotech

Grand Cayman, Cayman Islands

EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.

$41.0M raised
Dec 2021
Series B

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Exuma Biotech

How much funding has Exuma Biotech raised?
Exuma Biotech has raised $41.0M in total funding. The most recent round was Series B. The last funding was announced in December 2021.
Who are Exuma Biotech's investors?
Exuma Biotech's investors include BioAtla, MSD Partners, Americo Financial Life and Annuity, Shanghai Sinobioway Sunterra Biotechnology, SunTerra Capital.
Where is Exuma Biotech headquartered?
Exuma Biotech is headquartered in Grand Cayman, Cayman Islands.
What does Exuma Biotech do?
EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.
What stage is Exuma Biotech at?
Exuma Biotech is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Exuma Biotech — Funding & Investors." VCBacked, December 21, 2021, https://www.vcbacked.co/company/exuma-biotech. Accessed July 2, 2026.
APA
VCBacked. (2021). Exuma Biotech — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/exuma-biotech
Wikipedia (cite web)
{{cite web |title=Exuma Biotech — Funding & Investors |url=https://www.vcbacked.co/company/exuma-biotech |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .